TW377295B - Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines - Google Patents

Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines

Info

Publication number
TW377295B
TW377295B TW079108027A TW79108027A TW377295B TW 377295 B TW377295 B TW 377295B TW 079108027 A TW079108027 A TW 079108027A TW 79108027 A TW79108027 A TW 79108027A TW 377295 B TW377295 B TW 377295B
Authority
TW
Taiwan
Prior art keywords
hcv
detection
antibodies
peptides
diagnosis
Prior art date
Application number
TW079108027A
Other languages
Chinese (zh)
Inventor
Chang-Yi Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/558,799 external-priority patent/US5106726A/en
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Application granted granted Critical
Publication of TW377295B publication Critical patent/TW377295B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the application of a synthetic peptides for the detection of antibodies to HCV (the so-called NANBHV) and diagnosis of NANBH. Each of these peptides has an amino acid order qualifying the immune dominant region having protein and a non-structural multi-peptides, SOD/HCV C-100 and a hypothetic HCV structural (core) protein. This invention even applies a set of synthetic peptides in a specific order or the like for the detection of the HCV antibodies in the human secretion. The detection method includes ELISA and other immune tests. This invention relates also the method of application of these synthetic peptides, the like or the mixture in healthy mammals, including humans for the creation of an HCV antibody of high titration. By using a free, compound or polymerization of the synthetic peptides, synthetic vaccines are made of key compositions for fighting NANBH.
TW079108027A 1990-07-26 1990-09-24 Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines TW377295B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/558,799 US5106726A (en) 1990-02-16 1990-07-26 Synthetic peptides specific for the detection of antibodies to HCV

Publications (1)

Publication Number Publication Date
TW377295B true TW377295B (en) 1999-12-21

Family

ID=57942035

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079108027A TW377295B (en) 1990-07-26 1990-09-24 Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines

Country Status (1)

Country Link
TW (1) TW377295B (en)

Similar Documents

Publication Publication Date Title
CA2036463A1 (en) Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
JP4625215B2 (en) Early detection of flaviviruses using NS1 glycoprotein
DE69637914D1 (en) VEGETABLE AGAINST VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTIVE DISEASES IN PIGS
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
ATE244891T1 (en) METHOD FOR SELECTION AND PRODUCTION OF T-CELL PEPTIDES EPITOPES AND VACCINES WITH THESE EPITOPES
DE69840195D1 (en) METHOD AND COMPOSITIONS FOR PREVENTING THE REPRODUCTION OF HIV-1
WO2006041866A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
ATE442439T1 (en) MELANOMA ANTIGENE P15 AND THEIR APPLICATION IN DIAGNOSTIC AND THERAPEUTIC PROCEDURES
ATE355375T1 (en) BACTERIOFERRITIN FROM HELICOBACTER PYLORI
DE69738770D1 (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
SG95574A1 (en) Immunoreactive antigens of hepatitia e virus
WO2002057314A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
EP1572721A4 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
TW377295B (en) Stnthetic peptides specific for detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
EP1878797A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
Prokešová et al. Occurrence and specificity of human natural and in vitro induced antibodies to Nocardia opaca antigens
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
ATE119166T1 (en) HIV-RELATED PEPTIDES.
Cunliffe et al. An immunological analysis of the effects of bromelain on the mouse erythrocyte membrane
Truyen et al. Studies on the role of linear epitopes in neutralization of alphaviruses
EP0106837A2 (en) Use of peptides
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees